APO Research
Talk to an analyst

APO RESEARCH · REPORT

5-Hydroxytryptamine Receptor 2B

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global 5-Hydroxytryptamine Receptor 2B Industry Growth and Trends Forecast to 2032

26 December 202593 pages

Choose your research edition.

Industry Research5-Hydroxytryptamine Receptor 2B Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal 5-Hydroxytryptamine Receptor 2B Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal 5-Hydroxytryptamine Receptor 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 5-Hydroxytryptamine Receptor 2B Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal 5-Hydroxytryptamine Receptor 2B Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global 5-Hydroxytryptamine Receptor 2B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 5-Hydroxytryptamine Receptor 2B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 5-Hydroxytryptamine Receptor 2B is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 5-Hydroxytryptamine Receptor 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 5-Hydroxytryptamine Receptor 2B include Astellas Pharma Inc, Reviva Pharmaceuticals Inc, RaQualia Pharma Inc, Neurim Pharmaceuticals Ltd, Biofrontera AG and AnaMar AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 5-Hydroxytryptamine Receptor 2B market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 5-Hydroxytryptamine Receptor 2B market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 5-Hydroxytryptamine Receptor 2B market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 5-Hydroxytryptamine Receptor 2B.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 5-Hydroxytryptamine Receptor 2B market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

5-Hydroxytryptamine Receptor 2B Market by Company

Astellas Pharma Inc

Reviva Pharmaceuticals Inc

RaQualia Pharma Inc

Neurim Pharmaceuticals Ltd

Biofrontera AG

AnaMar AB

5-Hydroxytryptamine Receptor 2B Segment by Type

DDD-024

INV-240

RP-5063

Others

5-Hydroxytryptamine Receptor 2B Segment by Application

Obesity

Liver Fibrosis

Cirrhosis

Major Depressive Disorder

Others

5-Hydroxytryptamine Receptor 2B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5-Hydroxytryptamine Receptor 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 5-Hydroxytryptamine Receptor 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5-Hydroxytryptamine Receptor 2B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 5-Hydroxytryptamine Receptor 2B manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 5-Hydroxytryptamine Receptor 2B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DDD-024 Table 2. Major Company of INV-240 Table 3. Major Company of RP-5063 Table 4. Major Company of Others Table 5. Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 7. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type (2021-2026) Table 8. Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 9. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type (2021-2026) Table 10. Global 5-Hydroxytryptamine Receptor 2B Price by Type (2021-2026) & (US$/Unit) Table 11. Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2027-2032) & (W Units) Table 12. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type (2027-2032) Table 13. Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2027-2032) & (US$ Million) Table 14. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type (2027-2032) Table 15. Global 5-Hydroxytryptamine Receptor 2B Price by Type (2027-2032) & (US$/Unit) Table 16. North America 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 17. North America 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 18. Europe 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 19. Europe 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 23. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2026) & (US$ Million) Table 26. 5-Hydroxytryptamine Receptor 2B Industry Trends Table 27. 5-Hydroxytryptamine Receptor 2B Industry Drivers Table 28. 5-Hydroxytryptamine Receptor 2B Industry Opportunities and Challenges Table 29. 5-Hydroxytryptamine Receptor 2B Industry Restraints Table 30. Global 5-Hydroxytryptamine Receptor 2B Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global 5-Hydroxytryptamine Receptor 2B Revenue Market Share by Company (2021-2026) Table 32. Global 5-Hydroxytryptamine Receptor 2B Sales by Company (2021-2026) & (W Units) Table 33. Global 5-Hydroxytryptamine Receptor 2B Sales Share by Company (2021-2026) Table 34. Global 5-Hydroxytryptamine Receptor 2B Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global 5-Hydroxytryptamine Receptor 2B Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global 5-Hydroxytryptamine Receptor 2B Major Company Production Sites and Headquarters Table 37. Global 5-Hydroxytryptamine Receptor 2B Company, Product Type & Application Table 38. Global 5-Hydroxytryptamine Receptor 2B Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global 5-Hydroxytryptamine Receptor 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global 5-Hydroxytryptamine Receptor 2B Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global 5-Hydroxytryptamine Receptor 2B Sales by Region (2021-2026) & (W Units) Table 43. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Region (2021-2026) Table 44. Global 5-Hydroxytryptamine Receptor 2B Sales by Region (2021-2026) & (US$ Million) Table 45. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Region (2021-2026) Table 46. Global 5-Hydroxytryptamine Receptor 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global 5-Hydroxytryptamine Receptor 2B Sales by Region (2027-2032) & (W Units) Table 48. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Region (2027-2032) Table 49. Global 5-Hydroxytryptamine Receptor 2B Sales by Region (2027-2032) & (US$ Million) Table 50. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Region (2027-2032) Table 51. Global 5-Hydroxytryptamine Receptor 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 54. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application (2021-2026) Table 55. Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 56. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application (2021-2026) Table 57. Global 5-Hydroxytryptamine Receptor 2B Price by Application (2021-2026) & (US$/Unit) Table 58. Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2027-2032) & (W Units) Table 59. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application (2027-2032) Table 60. Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2027-2032) & (US$ Million) Table 61. Global 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application (2027-2032) Table 62. Global 5-Hydroxytryptamine Receptor 2B Price by Application (2027-2032) & (US$/Unit) Table 63. North America 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 64. North America 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 65. Europe 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 66. Europe 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 70. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2026) & (US$ Million) Table 73. Astellas Pharma Inc Company Information Table 74. Astellas Pharma Inc Business Overview Table 75. Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 77. Astellas Pharma Inc Recent Development Table 78. Reviva Pharmaceuticals Inc Company Information Table 79. Reviva Pharmaceuticals Inc Business Overview Table 80. Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 82. Reviva Pharmaceuticals Inc Recent Development Table 83. RaQualia Pharma Inc Company Information Table 84. RaQualia Pharma Inc Business Overview Table 85. RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 87. RaQualia Pharma Inc Recent Development Table 88. Neurim Pharmaceuticals Ltd Company Information Table 89. Neurim Pharmaceuticals Ltd Business Overview Table 90. Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 92. Neurim Pharmaceuticals Ltd Recent Development Table 93. Biofrontera AG Company Information Table 94. Biofrontera AG Business Overview Table 95. Biofrontera AG 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Biofrontera AG 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 97. Biofrontera AG Recent Development Table 98. AnaMar AB Company Information Table 99. AnaMar AB Business Overview Table 100. AnaMar AB 5-Hydroxytryptamine Receptor 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AnaMar AB 5-Hydroxytryptamine Receptor 2B Product Portfolio Table 102. AnaMar AB Recent Development Table 103. North America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 104. North America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026) & (W Units) Table 105. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share by Country (2021-2026) Table 106. North America 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032) & (W Units) Table 107. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share Forecast by Country (2027-2032) Table 108. North America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026) & (US$ Million) Table 110. North America 5-Hydroxytryptamine Receptor 2B Market Share by Country (2021-2026) Table 111. North America 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America 5-Hydroxytryptamine Receptor 2B Market Share Forecast by Country (2027-2032) Table 113. Europe 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. Europe 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026) & (W Units) Table 115. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share by Country (2021-2026) Table 116. Europe 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032) & (W Units) Table 117. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share Forecast by Country (2027-2032) Table 118. Europe 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe 5-Hydroxytryptamine Receptor 2B Market Share by Country (2021-2026) Table 121. Europe 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe 5-Hydroxytryptamine Receptor 2B Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026) & (W Units) Table 125. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032) & (W Units) Table 127. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Share by Country (2021-2026) Table 131. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Share Forecast by Country (2027-2032) Table 133. Latin America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 134. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026) & (W Units) Table 135. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share by Country (2021-2026) Table 136. Latin America 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032) & (W Units) Table 137. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America 5-Hydroxytryptamine Receptor 2B Market Share by Country (2021-2026) Table 141. Latin America 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America 5-Hydroxytryptamine Receptor 2B Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026) & (W Units) Table 145. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032) & (W Units) Table 147. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Share by Country (2021-2026) Table 151. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. 5-Hydroxytryptamine Receptor 2B Distributors List Table 156. 5-Hydroxytryptamine Receptor 2B Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. 5-Hydroxytryptamine Receptor 2B Image Figure 2. Global 5-Hydroxytryptamine Receptor 2B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 5-Hydroxytryptamine Receptor 2B Market Size (2021-2032) & (US$ Million) Figure 4. Global 5-Hydroxytryptamine Receptor 2B Sales (2021-2032) & (W Units) Figure 5. DDD-024 Image Figure 6. Global DDD-024 Sales YoY Growth (2021-2032) & (W Units) Figure 7. INV-240 Image Figure 8. Global INV-240 Sales YoY Growth (2021-2032) & (W Units) Figure 9. RP-5063 Image Figure 10. Global RP-5063 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global 5-Hydroxytryptamine Receptor 2B Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global 5-Hydroxytryptamine Receptor 2B Market Share by Type 2025 VS 2032 Figure 15. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type in 2025 Figure 16. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type in 2025 Figure 17. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type in 2025 Figure 18. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type in 2025 Figure 21. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type in 2025 Figure 22. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 5-Hydroxytryptamine Receptor 2B Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Obesity Image Figure 28. Global Obesity Sales YoY Growth (2021-2032) & (W Units) Figure 29. Liver Fibrosis Image Figure 30. Global Liver Fibrosis Sales YoY Growth (2021-2032) & (W Units) Figure 31. Cirrhosis Image Figure 32. Global Cirrhosis Sales YoY Growth (2021-2032) & (W Units) Figure 33. Major Depressive Disorder Image Figure 34. Global Major Depressive Disorder Sales YoY Growth (2021-2032) & (W Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global 5-Hydroxytryptamine Receptor 2B Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global 5-Hydroxytryptamine Receptor 2B Market Share by Application 2025 VS 2032 Figure 39. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application in 2025 Figure 40. North America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application in 2025 Figure 41. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application in 2025 Figure 42. Europe 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application in 2025 Figure 45. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application in 2025 Figure 46. Latin America 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Market Share in Value by Application in 2025 Figure 49. North America 5-Hydroxytryptamine Receptor 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America 5-Hydroxytryptamine Receptor 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America 5-Hydroxytryptamine Receptor 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe 5-Hydroxytryptamine Receptor 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe 5-Hydroxytryptamine Receptor 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe 5-Hydroxytryptamine Receptor 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America 5-Hydroxytryptamine Receptor 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America 5-Hydroxytryptamine Receptor 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America 5-Hydroxytryptamine Receptor 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. 5-Hydroxytryptamine Receptor 2B Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. 5-Hydroxytryptamine Receptor 2B Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • DDD-024
  • INV-240
  • RP-5063
  • Others
Applications
  • Obesity
  • Liver Fibrosis
  • Cirrhosis
  • Major Depressive Disorder
  • Others
Companies covered
  • Astellas Pharma Inc
  • Reviva Pharmaceuticals Inc
  • RaQualia Pharma Inc
  • Neurim Pharmaceuticals Ltd
  • Biofrontera AG
  • AnaMar AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 5-Hydroxytryptamine Receptor 2B Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 5-Hydroxytryptamine Receptor 2B Sales Estimates and Forecasts (2021-2032)
  5. 1.3 5-Hydroxytryptamine Receptor 2B Market by Type
  6. 1.3.1 DDD-024
  7. 1.3.2 INV-240
  8. 1.3.3 RP-5063
  9. 1.3.4 Others
  10. 1.4 Global 5-Hydroxytryptamine Receptor 2B Market Size by Type
  11. 1.4.1 Global 5-Hydroxytryptamine Receptor 2B Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global 5-Hydroxytryptamine Receptor 2B Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global 5-Hydroxytryptamine Receptor 2B Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 5-Hydroxytryptamine Receptor 2B Industry Trends
  2. 2.2 5-Hydroxytryptamine Receptor 2B Industry Drivers
  3. 2.3 5-Hydroxytryptamine Receptor 2B Industry Opportunities and Challenges
  4. 2.4 5-Hydroxytryptamine Receptor 2B Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 5-Hydroxytryptamine Receptor 2B Revenue (2021-2026)
  2. 3.2 Global Top Players by 5-Hydroxytryptamine Receptor 2B Sales (2021-2026)
  3. 3.3 Global Top Players by 5-Hydroxytryptamine Receptor 2B Price (2021-2026)
  4. 3.4 Global 5-Hydroxytryptamine Receptor 2B Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 5-Hydroxytryptamine Receptor 2B Major Company Production Sites & Headquarters
  6. 3.6 Global 5-Hydroxytryptamine Receptor 2B Company, Product Type & Application
  7. 3.7 Global 5-Hydroxytryptamine Receptor 2B Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 5-Hydroxytryptamine Receptor 2B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 5-Hydroxytryptamine Receptor 2B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 5-Hydroxytryptamine Receptor 2B Tier 1, Tier 2, and Tier 3
4 5-Hydroxytryptamine Receptor 2B Regional Status and Outlook
  1. 4.1 Global 5-Hydroxytryptamine Receptor 2B Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 5-Hydroxytryptamine Receptor 2B Historic Market Size by Region
  3. 4.2.1 Global 5-Hydroxytryptamine Receptor 2B Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 5-Hydroxytryptamine Receptor 2B Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 5-Hydroxytryptamine Receptor 2B Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 5-Hydroxytryptamine Receptor 2B Forecasted Market Size by Region
  7. 4.3.1 Global 5-Hydroxytryptamine Receptor 2B Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 5-Hydroxytryptamine Receptor 2B Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 5-Hydroxytryptamine Receptor 2B Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 5-Hydroxytryptamine Receptor 2B by Application
  1. 5.1 5-Hydroxytryptamine Receptor 2B Market by Application
  2. 5.1.1 Obesity
  3. 5.1.2 Liver Fibrosis
  4. 5.1.3 Cirrhosis
  5. 5.1.4 Major Depressive Disorder
  6. 5.1.5 Others
  7. 5.2 Global 5-Hydroxytryptamine Receptor 2B Market Size by Application
  8. 5.2.1 Global 5-Hydroxytryptamine Receptor 2B Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global 5-Hydroxytryptamine Receptor 2B Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global 5-Hydroxytryptamine Receptor 2B Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astellas Pharma Inc
  2. 6.1.1 Astellas Pharma Inc Company Information
  3. 6.1.2 Astellas Pharma Inc Business Overview
  4. 6.1.3 Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
  6. 6.1.5 Astellas Pharma Inc Recent Developments
  7. 6.2 Reviva Pharmaceuticals Inc
  8. 6.2.1 Reviva Pharmaceuticals Inc Company Information
  9. 6.2.2 Reviva Pharmaceuticals Inc Business Overview
  10. 6.2.3 Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
  12. 6.2.5 Reviva Pharmaceuticals Inc Recent Developments
  13. 6.3 RaQualia Pharma Inc
  14. 6.3.1 RaQualia Pharma Inc Company Information
  15. 6.3.2 RaQualia Pharma Inc Business Overview
  16. 6.3.3 RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
  18. 6.3.5 RaQualia Pharma Inc Recent Developments
  19. 6.4 Neurim Pharmaceuticals Ltd
  20. 6.4.1 Neurim Pharmaceuticals Ltd Company Information
  21. 6.4.2 Neurim Pharmaceuticals Ltd Business Overview
  22. 6.4.3 Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Product Portfolio
  24. 6.4.5 Neurim Pharmaceuticals Ltd Recent Developments
  25. 6.5 Biofrontera AG
  26. 6.5.1 Biofrontera AG Company Information
  27. 6.5.2 Biofrontera AG Business Overview
  28. 6.5.3 Biofrontera AG 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Biofrontera AG 5-Hydroxytryptamine Receptor 2B Product Portfolio
  30. 6.5.5 Biofrontera AG Recent Developments
  31. 6.6 AnaMar AB
  32. 6.6.1 AnaMar AB Company Information
  33. 6.6.2 AnaMar AB Business Overview
  34. 6.6.3 AnaMar AB 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AnaMar AB 5-Hydroxytryptamine Receptor 2B Product Portfolio
  36. 6.6.5 AnaMar AB Recent Developments
7 North America by Country
  1. 7.1 North America 5-Hydroxytryptamine Receptor 2B Sales by Country
  2. 7.1.1 North America 5-Hydroxytryptamine Receptor 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026)
  4. 7.1.3 North America 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032)
  5. 7.2 North America 5-Hydroxytryptamine Receptor 2B Market Size by Country
  6. 7.2.1 North America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026)
  8. 7.2.3 North America 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 5-Hydroxytryptamine Receptor 2B Sales by Country
  2. 8.1.1 Europe 5-Hydroxytryptamine Receptor 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026)
  4. 8.1.3 Europe 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 5-Hydroxytryptamine Receptor 2B Market Size by Country
  6. 8.2.1 Europe 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026)
  8. 8.2.3 Europe 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Country
  2. 9.1.1 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size by Country
  6. 9.2.1 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 5-Hydroxytryptamine Receptor 2B Sales by Country
  2. 10.1.1 South America 5-Hydroxytryptamine Receptor 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026)
  4. 10.1.3 South America 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032)
  5. 10.2 South America 5-Hydroxytryptamine Receptor 2B Market Size by Country
  6. 10.2.1 South America 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026)
  8. 10.2.3 South America 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Country
  2. 11.1.1 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size by Country
  6. 11.2.1 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 5-Hydroxytryptamine Receptor 2B Value Chain Analysis
  2. 12.1.1 5-Hydroxytryptamine Receptor 2B Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 5-Hydroxytryptamine Receptor 2B Production Mode & Process
  7. 12.2 5-Hydroxytryptamine Receptor 2B Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 5-Hydroxytryptamine Receptor 2B Distributors
  10. 12.2.3 5-Hydroxytryptamine Receptor 2B Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst